Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofibromin 1 pseudogene 7 (NF1P7) is one of several pseudogenes derived from duplication and transposition events involving portions of the functional NF1 gene that encodes the tumor suppressor neurofibromin. These pseudogenes are present in the human genome on various chromosomes and share sequence similarity with segments of the functional NF1 gene, but they do not encode a functional protein and have no documented or predicted biological role. NF1P7 is not considered a therapeutic target, and there are no known disease associations, biomarker roles, or drug interactions for this pseudogene[3][6]. If your interest is in the functional NF1 gene or the neurofibromin protein, that is a well-characterized tumor suppressor and disease gene—please clarify if that is the intended target. Otherwise, for "NF1P7", it is accurate to treat this entry as non-functional and not therapeutically relevant[3][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofibromin 1 pseudogene 7 (NF1P7).